Our long-term objective is to improve therapies for progressive pulmonary hypertension (PH) in infants suffering from chronic cardiopulmonary disorders associated with persistent or episodic hypoxia. To do this, we developed a model of PH in newborn pigs. We have shown that PH develops within 3 days exposure to hypoxia and worsens when hypoxic exposure is extended to 10 days. The progressive development of PH in newborn pigs is accompanied by NO signaling impairments, including eNOS uncoupling. These findings serve as the basis for testing the hypothesis that restoring eNOS uncoupling will improve NO production and ameliorate PH. Our experimental design will test the hypothesis that combined treatment with the L-arginine- NO precursor L-citrulline, plus the co-factor BH4, restores pulmonary vascular NO signaling and ameliorates PH more effectively than either treatment alone, by more effectively recoupling eNOS, shifting the balance of eNOS-generated free radicals away from superoxide and toward NO production.
The aims of this proposal are to: 1) evaluate the mechanisms by which combined therapy with L-citrulline and BH4 increase pulmonary vascular NO production 2) establish the efficacy and safety of combined vs sole therapy with oral L-citrulline or BH4 to ameliorate chronic hypoxia-induced PH. Studies will evaluate the ability of these therapies to arrest the progressive development of PH when given chronically to piglets exposed to hypoxia and to acutely improve pulmonary vascular responses to NO when administered to piglets with PH. As part of the first aim, studies will address current gaps in our knowledge about the oxidation and loss of BH4 in the neonatal pulmonary circulation. This will include delineating the sources of superoxide, including NADPH oxidase family enzymes, that contribute to oxidation of BH4, and, hence, uncoupled eNOS. As part of the second aim, we will determine if combined therapy with L-citrulline and BH4 improves the parameters of NO signaling that are perturbed with chronic hypoxia. These studies will provide invaluable information about restoring impaired NO signaling pathways that can ultimately be translated into important clinical trials to treat infants with chronic cardiopulmonary conditions and PH due in part to hypoxia.

Public Health Relevance

Pulmonary hypertension is a well-recognized complication of infants with chronic lung and heart disorders. Currently there are few good options for treating these infants. The goal of this project is to use a relevant animal model to help us understand why infants with lung and heart disorders associated with chronic or intermittent hypoxia develop progressive pulmonary hypertension, determine what happens in the lung blood vessels during disease development, and develop treatments for this disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56HL097566-05
Application #
9130378
Study Section
Respiratory Integrative Biology and Translational Research Study Section (RIBT)
Program Officer
Lin, Sara
Project Start
2015-09-14
Project End
2016-08-31
Budget Start
2015-09-14
Budget End
2016-08-31
Support Year
5
Fiscal Year
2015
Total Cost
$561,197
Indirect Cost
$199,614
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Dikalova, Anna; Aschner, Judy L; Kaplowitz, Mark R et al. (2016) Tetrahydrobiopterin oral therapy recouples eNOS and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. Am J Physiol Lung Cell Mol Physiol 311:L743-L753
Dikalova, Anna; Fagiana, Angela; Aschner, Judy L et al. (2014) Sodium-coupled neutral amino acid transporter 1 (SNAT1) modulates L-citrulline transport and nitric oxide (NO) signaling in piglet pulmonary arterial endothelial cells. PLoS One 9:e85730
Fike, Candice D; Sidoryk-Wegrzynowicz, Marta; Aschner, Michael et al. (2012) Prolonged hypoxia augments L-citrulline transport by system A in the newborn piglet pulmonary circulation. Cardiovasc Res 95:375-84